Skip to main content
Toggle navigation
Login
Home
Back
Favorite
0
Like
Facebook
Tweet
Session VII: Emerging Treatment Approaches for Esophagogastric Cancer
Debate: Checkpoint Inhibitors as First-Line Treatment for All Patients With Gastric Cancer? Yes vs. No - NO
Friday, April 22, 2022
9:13 AM – 9:21 AM
Debate Speaker(s)
Anwaar Saeed, MD
University of Kansas Cancer Center